The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children.
Open accessAbstract
Platelet-activating factor (PAF) acetylhydrolase has been recognized as an enzyme that inactivates PAF. We developed a convenient and reproducible method for determining human serum PAF acetylhydrolase activity. The assay was based on measurement of [14C]acetate produced from 1-O-alkyl-2-[14C]-acetyl-sn-glycero-3-phosphocholine upon precipitation of the complex of radioactive substrate and albumin with TCA. The apparent Km value of PAF acetylhydrolase (near the physiological concentration of serum protein) was 1.5 X 10(-4) M PAF. 32 subjects with serum PAF acetylhydrolase deficiency were found among 816 healthy Japanese adults. The low PAF acetylhydrolase activity in the deficient serum might not be due to the presence of enzyme inhibitor. Both the sensitivity to PAF and the metabolism of PAF in platelets from PAF acetylhydrolase-deficient subjects were almost the same as those of normal subjects. Deficiency in serum PAF acetylhydrolase appeared to be transmitted by autosomal recessive heredity among five Japanese families. Among healthy adults, healthy children, and asthmatic children, who were grouped into five classes on the basis of respiratory symptoms (remission, wheezy, mild, moderate, and severe groups), the probability of PAF acetylhydrolase deficiency was significantly higher in groups with severe symptoms (moderate and severe) (P less than 0.01). These results suggest that deficiency of serum PAF acetylhydrolase might be one of the factors leading to severe respiratory symptoms in asthmatic children.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Demopoulos, C. A., Pinckard, R. N., & Hanahan, D. J. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83523-8 · Cited by 1,202
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
Wardlaw, A. J., Moqbel, R., Cromwell, O., & Kay, A. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112765 · Cited by 568
Antihypertensive activity of an alkyl ether analog of phosphatidylcholine
Blank, M. L., Snyder, F., Byers, L. W., Brooks, B., & Muirhead, E. E. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91163-x · Cited by 558
Hanahan, D. J., Demopoulos, C. A., Liehr, J., & Pinckard, R. N. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70658-9 · Cited by 407
Stafforini, D. M., McIntyre, T. M., Carter, M. E., & Prescott, S. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61335-3 · Cited by 398
Doebber, T. W., Wu, M. S., Robbins, J. C., Choy, B. M., Chang, M. N., & Shen, T. Y. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(85)80014-0 · Cited by 294
Chilton, F. H., Ellis, J. M., Olson, S. C., & Wykle, R. L. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)71312-8 · Cited by 293
Farr, R. S., Cox, C. P., Wardlow, M. L., & Jorgensen, R. (1980) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(80)90044-6 · Cited by 203
Selective acylation of lyso platelet activating factor by arachidonate in human neutrophils.
Chilton, F. H., O’Flaherty, J. T., Ellis, J. M., et al. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32170-7 · Cited by 148
Metabolic fate of platelet-activating factor in neutrophils.
Chilton, F. H., O’Flaherty, J. T., Ellis, J. M., et al. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32417-7 · Cited by 96
Malone, B., Lee, T., & Snyder, F. F. C. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89625-9 · Cited by 84
Occurrence of an endogenous inhibitor of platelet-activating factor in rat liver.
Miwa, M., Hill, C. E., Kumar, R., et al. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75812-8 · Cited by 53
Self-citationExtracellular and Intracellular Activities of PAF
Henson, P. M. (1987) · Springer eBooks · doi:10.1007/978-1-4684-5284-6_11 · Cited by 19
Sugatani, J., Miwa, M., & Hanahan, D. J. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45637-2 · Cited by 19
Self-citation
Cited by
Prescott, S. M., Zimmerman, G. A., & McIntyre, T. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38167-5 · Cited by 889
Kudo, I., & Murakami, M. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00020-5 · Cited by 757
Platelet-Activating Factor and Related Lipid Mediators
Prescott, S. M., Zimmerman, G. A., Stafforini, D. M., & McIntyre, T. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.419 · Cited by 748
Inflammatory Mediators of Asthma: An Update
Barnes, P. J., Chung, K. F., & Page, C. P. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01381-4 · Cited by 717
Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis
Vadas, P., Gold, M., Perelman, B., Liss, G. M., Lack, G., Blyth, T., Simons, F. E. R., Simons, K. J., Cass, D., & Yeung, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070030 · Cited by 526
Metadata
- Authors
- Miwa, M., Miyake, T., Yamanaka, T., Sugatani, J., Suzuki, Y., Sakata, S., Araki, Y., & Matsumoto, M.
- Venue
- Journal of Clinical Investigation
- Published
- 1988-12-01
- Volume
- 82
- Issue
- 6
- Pages
- 1983-1991
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2121121770
- Cited by
- 279
- References
- 15
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.